Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer (ACC).

被引:0
|
作者
Melichar, B
Tabernero, J
Casado, E
Bridgewater, J
Hamm, J
Sklenar, I
Holland, J
Cheung, W
Zaknoen, S
Johri, A
机构
[1] Charles Univ Prague, Sch Med, CS-50165 Hradec Kralove, Czech Republic
[2] Hosp Gen Valle Hebron, Barcelona, Spain
[3] UCL Royal Free & Univ Coll, Sch Med, London, England
[4] Norton Healthcare, Louisville Oncol, Louisville, KY USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:292S / 292S
页数:1
相关论文
共 50 条
  • [1] Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer
    Melichar, Bohuslav
    Casado, Esther
    Tabemero, Josep
    Hosseinzadeh, Sharareh
    Hamm, John
    Wadler, Scott
    Bridgewater, John
    Holland, Jaymes
    Sklenar, Ivo
    Johri, Anandhi
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 85 - 85
  • [2] Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
    Melichar, B.
    Casado, E.
    Bridgewater, J.
    Bennouna, J.
    Campone, M.
    Vitek, P.
    Delord, J-P
    Cerman, J., Jr.
    Salazar, R.
    Dvorak, J.
    Sguotti, C.
    Urban, P.
    Viraswami-Appanna, K.
    Tan, E.
    Tabernero, J.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (11) : 1646 - 1653
  • [3] Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
    B Melichar
    E Casado
    J Bridgewater
    J Bennouna
    M Campone
    P Vitek
    J-P Delord
    J Cerman
    R Salazar
    J Dvorak
    C Sguotti
    P Urban
    K Viraswami-Appanna
    E Tan
    J Tabernero
    [J]. British Journal of Cancer, 2011, 105 : 1646 - 1653
  • [4] Phase I trial of patupilone plus carboplatin in patients with advanced cancer
    Gore, Martin
    Kaye, Stan
    Oza, Amit
    Keyzor, Carmel
    Pyle, Linda
    Pereno, Raffaele
    Sklenar, Ivo
    Johri, Anandhi
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 126 - 127
  • [5] Phase I trial of patupilone plus carboplatin in patients with advanced cancer.
    Gore, M
    Kaye, S
    Oza, A
    Keyzor, C
    Pyle, L
    Pereno, R
    Sklenar, I
    Zaknoen, S
    Johri, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 476S - 476S
  • [6] Phase I trial of patupilone (P) and RAD001 in patients (pts) with advanced solid tumors
    Stein, M. N.
    Knox, B.
    Wesolowsky, E.
    Levitt, M.
    Moss, R.
    Poplin, E.
    Mehnert, J.
    Gounder, M.
    Goodin, S.
    DiPaola, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    Schelman, William
    Morgan-Meadows, Sherry
    Bailey, Howard
    Holen, Kyle
    Thomas, James P.
    Eickhoff, Jens
    Brandon, Heidi
    Oliver, Kate
    Alberti, Dona
    Wilding, George
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (04) : 727 - 733
  • [8] A phase lb and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer
    Forster, Martin
    Kaye, Stan
    Oza, Amit
    Sklenar, Ivo
    Johri, Anandhi
    Cheung, Wing
    Zaknoen, Sara
    Gore, Martin
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4178 - 4184
  • [9] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    William Schelman
    Sherry Morgan-Meadows
    Howard Bailey
    Kyle Holen
    James P. Thomas
    Jens Eickhoff
    Heidi Brandon
    Kate Oliver
    Dona Alberti
    George Wilding
    [J]. Cancer Chemotherapy and Pharmacology, 2008, 62 : 727 - 733
  • [10] A PHASE I TRIAL OF IRINOTECAN (IRI) AND BKM120 IN PREVIOUSLY TREATED PATIENTS (PTS) WITH METASTIC COLORECTAL CANCER (MCRC)
    Baranda, J. C.
    Reed, G.
    Williamson, S.
    Dickman, E.
    Stoltz, M.
    Madan, R.
    Wright, L.
    Bhalla, K.
    Godwin, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 223 - 223